Status: current, Defined. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2537171000168110 | Temozolomide (Apotex) (temozolomide 20 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2537181000168113 | Temozolomide (Apotex) 20 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Temozolomide (Apotex) 20 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Temozolomide (Apotex) 20 mg capsule | Is a | Temozolomide (Apotex) | true | Inferred relationship | Some | ||
| Temozolomide (Apotex) 20 mg capsule | Is a | temozolomide 20 mg capsule | true | Inferred relationship | Some | ||
| Temozolomide (Apotex) 20 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Temozolomide (Apotex) 20 mg capsule | has manufactured dose form | hard capsule | false | Inferred relationship | Some | ||
| Temozolomide (Apotex) 20 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 1332226019 | |
| Temozolomide (Apotex) 20 mg capsule | has Australian BoSS | temozolomide | true | Inferred relationship | Some | 1332226018 | |
| Temozolomide (Apotex) 20 mg capsule | has intended active ingredient | temozolomide | true | Inferred relationship | Some | 1332226018 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Temozolomide (Apotex) 20 mg capsule, 5 | has TPUU | True | Temozolomide (Apotex) 20 mg capsule | Inferred relationship | Some | 1 |
| Temozolomide (Apotex) 20 mg capsule, 5, bottle | has TPUU | True | Temozolomide (Apotex) 20 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR